Suppr超能文献

[鼻腔和鼻前庭恶性肿瘤的放射治疗结果]

[Radiotherapy results in the treatment of malignant tumors of the nasal fossa and vestibule].

作者信息

Gabriele P, Orecchia R, Valente G, Ruo Redda M G, Pisani P, Krengli M, Negri G L

机构信息

Divisione di Radioterapia, Università Torino.

出版信息

Radiol Med. 1994 Jun;87(6):853-7.

PMID:8041941
Abstract

The authors report their personal experience in the treatment of malignant tumors of the nasal cavity and vestibule with irradiation alone or combined with surgery. From January 1976 to December 1989 we treated 40 patients with 22 squamous cell carcinomas, 12 adenocarcinomas or other glandular types, and 6 other histologic types of lesions: 23 patients received irradiation alone and 17 patients were treated with surgery and postoperative irradiation. The protocol included surgery as the treatment of choice: irradiation alone was administered to inoperable tumors or to the patients refusing surgery; postoperative irradiation was given when macroscopic or microscopic residual disease was observed after surgery or to particular histologic types. In the whole series of patients, 3- and 5-year local control rates were 70% and 50%, respectively; better results were obtained in the patients receiving the combined treatment (64% at 5 years) than in the patients receiving irradiation alone (43% at 5 years). Disease stages (I and II versus III and IV) were the only statistically significant prognostic factor; worse results in irradiated patients might be due to the higher rate of advanced lesions in this group. Salvage therapy (irradiation in 8 cases, surgery in 2 and chemotherapy in 1) was successfully performed in 5 of 11 treated patients. The 3- and 5-year overall survival rates were 88% and 70%, respectively. Severe complication rate was lower than 10% (3 cases only).

摘要

作者报告了他们单独使用放疗或联合手术治疗鼻腔和前庭恶性肿瘤的个人经验。1976年1月至1989年12月,我们共治疗了40例患者,其中22例为鳞状细胞癌,12例为腺癌或其他腺型肿瘤,6例为其他组织学类型的病变:23例患者仅接受放疗,17例患者接受手术及术后放疗。治疗方案以手术为首选:无法手术的肿瘤或拒绝手术的患者接受单纯放疗;术后放疗适用于术后观察到有肉眼或显微镜下残留病灶的患者或特定组织学类型的患者。在整个患者系列中,3年和5年的局部控制率分别为70%和50%;联合治疗的患者(5年时为64%)比单纯放疗的患者(5年时为43%)取得了更好的效果。疾病分期(I和II期与III和IV期)是唯一具有统计学意义的预后因素;放疗患者的结果较差可能是由于该组中晚期病变的发生率较高。11例接受治疗的患者中有5例成功进行了挽救治疗(8例放疗,2例手术,1例化疗)。3年和5年的总生存率分别为88%和70%。严重并发症发生率低于10%(仅3例)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验